|
Volumn , Issue 170, 2005, Pages 619-644
|
Protection of endothelial function.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA TOCOPHEROL;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CHOLESTEROL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN 1;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ANIMAL;
ATHEROSCLEROSIS;
DRUG EFFECT;
HUMAN;
METABOLISM;
PHYSIOLOGY;
REVIEW;
VASCULAR ENDOTHELIUM;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMALS;
ATHEROSCLEROSIS;
CALCIUM CHANNEL BLOCKERS;
CHOLESTEROL;
CYCLOOXYGENASE INHIBITORS;
ENDOTHELIN-1;
ENDOTHELIUM, VASCULAR;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPOPROTEINS, HDL;
VITAMIN E;
|
EID: 33645769796
PISSN: 01712004
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (17)
|
References (104)
|